Skip to main content

Table 1 Baseline patient profile

From: Safety and efficacy of biocompatible perfusion strategy in a contemporary series of patients undergoing coronary artery bypass grafting – a two-center study

Variable

Percent or mean, SD (Median, Range), (n = 964)

Age (Years)

66 ± 11 (66, 32–89)

Gender (M/F)

804 (83%) / 160 (17%)

Hypertension

694 (72%)

Diabetes mellitus

345 (36%)

Peripheral vascular disease

184 (19%)

Prior cerebrovascular accident

62 (6%)

Renal failure on dialysis

13 (1.3%)

Chronic obstructive pulmonary disease

90 (9%)

Prior myocardial infarction

556 (58%)

Prior Percutaneous Coronary Intervention

282 (29%)

Preoperative intra-aortic balloon pump

42 (4.3%)

Preoperative medications

 

 Aspirin

878 (91%)

 Second antiplatelet agent within 5 days

36 (4%)

 Heparin

342 (35%)

 Anti-arrhythmic medication

32 (3%)

 Immunosuppression

19 (2%)

Left ventricular ejection fraction (%)

53 ± 12 (55, 5–86)

Extent of coronary artery disease

 

 Left main disease

386 (40%)

 Single vessel

48 (5%)

 Two vessel

287 (30%)

 Three vessel

628 (65%)